Sertraline and Fosphenytoin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Fosphenytoin
Sertraline
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
These two medicines can affect each other in a few ways. Fosphenytoin (a seizure medicine that turns into phenytoin in your body) is a drug where even small changes in blood level matter. When taken with sertraline, phenytoin levels can rise, which may cause side effects like dizziness, unsteady walking, slurred speech, or feeling very drowsy. At the same time, your sertraline may work less well. Both drugs can also affect the heart's rhythm.
This sounds like a lot, but it is very manageable. Your care team can check your phenytoin blood levels and adjust doses as needed. Please keep taking both exactly as prescribed and talk with your doctor or pharmacist.
Direction/mechanism: Fosphenytoin is a prodrug of phenytoin (CYP2C9/2C19 substrate). Sertraline can inhibit phenytoin metabolism, increasing phenytoin exposure and toxicity risk, while phenytoin's enzyme-inducing activity reduces sertraline exposure and efficacy. Both agents carry additive QTc-prolongation risk.
- Severity: Major; evidence: probable; onset: unspecified.
- Monitor: phenytoin serum levels, signs of toxicity (nystagmus, ataxia, sedation), antidepressant response, and ECG/QTc in at-risk patients.
- Manage: individualize fosphenytoin and sertraline dosing when adding/withdrawing fosphenytoin; reduce phenytoin/fosphenytoin dose if levels rise. Avoid combination where possible given QTc risk.
What happens
Increased risk of fosphenytoin toxicity, reduced efficacy of sertraline and an increased risk of QT interval prolongation
Interaction Deep Dive
Do not combine agents recognized for prolonging the QTc interval. Taking sertraline together with other QTc-prolonging drugs raises the likelihood of QTc prolongation and/or ventricular arrhythmias 1. Because phenytoin or fosphenytoin (the prodrug of phenytoin) acts as a CYP2C9 and CYP2C19 substrate as well as a potent inducer of CYP enzymes, using it alongside sertraline can heighten fosphenytoin exposure, potentially producing toxicity, while diminishing sertraline exposure 3. For the best clinical results, evaluate whether the doses of fosphenytoin and sertraline should be modified whenever fosphenytoin is introduced into or removed from a patient's regimen. During co-administration, track the fosphenytoin serum drug concentration 7, and lower the dose of phenytoin or fosphenytoin (the prodrug of phenytoin) if warranted 1.
Why it happens (mechanism)
Inhibition of CYP-mediated metabolism of fosphenytoin; induction of CYP-mediated metabolism of sertraline; additive QT interval prolongation
How to manage this interaction
Both medicines are important, so the goal is to use them together safely if your team decides to.
- Keep taking both as prescribed unless your prescriber tells you otherwise.
- Your team may check fosphenytoin (phenytoin) blood levels and adjust the dose, especially when sertraline is started, changed, or stopped.
- Doses of one or both may need to be individualized by your care team.
- Because both can affect heart rhythm, your team may monitor you more closely or consider an alternative.
Tell your pharmacist or doctor about any new dizziness, unsteadiness, drowsiness, fainting, palpitations, or return of depression symptoms.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
2 reports — tap to read
a) Two elderly patients experienced raised serum phenytoin concentrations while receiving concurrent sertraline. Patient 1, a 78-year old man, was on phenytoin 300 mg per day along with several other drugs. When sertraline 25 mg every night was added to treat depression, his serum phenytoin level climbed from 5.2 mcg/mL to 12.3 mcg/mL. Following successive increases of the sertraline dose to 75 mg per day, the patient's serum phenytoin level rose to 30.9 mcg/mL. Phenytoin was stopped but was subsequently restarted successfully at a dose of 200 mg per day. Sertraline 100 mg per day was also given without additional adverse effects. Patient 2, an 85-year old man, had increased serum phenytoin levels (from 15.6 mcg/mL to 20 mcg/mL) after sertraline 25 mg every other day was added to phenytoin 260 mg per day. The authors advise measuring serum phenytoin concentrations within one week of beginning sertraline therapy or making a change in the sertraline dose 4.
b) Sertraline is recognized as a moderate to weak inhibitor of the CYP2D6 isoenzyme and is thought to inhibit the CYP2C9 and CYP3A4 hepatic isoenzymes. Phenytoin metabolism may involve the CYP2D6 5 and CYP2C9 hepatic isoenzymes 62.
Common questions
Can I take Sertraline and Fosphenytoin together?
Combining fosphenytoin and sertraline can raise phenytoin levels (toxicity risk), weaken sertraline's effect, and add heart-rhythm risk, so your care team may adjust doses, check phenytoin blood levels, and monitor closely. Keep taking both as prescribed and report new side effects. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Fosphenytoin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Sertraline and Fosphenytoin interaction managed?
Both medicines are important, so the goal is to use them together safely if your team decides to. Keep taking both as prescribed unless your prescriber tells you otherwise. Your team may check fosphenytoin (phenytoin) blood levels and adjust the dose, especially when sertraline is started, changed, or stopped. Doses of one or both may need to be individualized by your care team. Because both can a… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Fosphenytoin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (7)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- DeVane CL: Pharmacokinetics of the newer antidepressants: clinical relevance. Am J Med 1994; 97(suppl 6A):13S-23S. PubMed
- Product Information: Dilantin-125(R) oral suspension, phenytoin oral suspension. Parke-Davis (per FDA), New York, NY, 2013. DailyMed
- Haselberger MB, Freedman LS, & Tolbert S: Elevated serum phenytoin concentrations associated with coadministration of sertraline. J Clin Psychopharmacol 1997; 17:107-109. PubMed
- Murray M: P450 enzymes: inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet 1992; 23:132-146.
- Riesenman C: Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal. Pharmacotherapy 1995; 15(6 part 2):84S-99S. DOI
- Product Information: FOSPHENYTOIN SODIUM intravenous and intramuscular injection, fosphenytoin sodium intravenous and intramuscular injection. SAGENT Pharmaceuticals (per Dailymed), Schaumburg, IL, 2024. DailyMed
Keep reading about Fosphenytoin
Keep reading about Sertraline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist